With US sales recovering, Lupin Q2 profit up 97% over Q1 to Rs 211 cr

Mumbai based drug maker Lupin reported a consolidated net profit of Rs 211 crore for the second quarter of the ongoing fiscal primarily led by a recovery in US sales. The company had reported a net loss of Rs 185.3 crore in the corresponding period last year.

Sequentially, Lupin's net profit jumped 97.4 percent over the previous quarter. The revenues, however, dropped by 1.2 percent  on a year on year (YoY) basis to Rs 3,835 crore, but sequentially the revenues rose 8.7 percent. The earnings before income tax, depreciation and amortisation (Ebitda) fell 21.1 percent YoY to Rs 606 crore